CIK 0001517022 · Large accelerated filer
Akebia Therapeutics, Inc.
Sign in to watch- Ticker
- AKBA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 208756903
- Phone
- 617-871-2098
- Business address
- 180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
- 4 Grant or award SVP, Chief Medical Officer acquired 204,000 shares (grant or award)
- 4 Grant or award SVP, Chief Legal Officer acquired 190,000 shares (grant or award)
- 4 Grant or award SVP, Chief Accounting Officer acquired 79,000 shares (grant or award)
- 4 Grant or award SVP, CFO, CBO & Treasurer acquired 204,000 shares (grant or award)
- 4 Grant or award CEO and President acquired 743,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 8-K Event Material agreement · New debt or obligation · Executive or director change
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 8-K Event Results of operations · Regulation FD disclosure
- 8-K Event Material agreement · Regulation FD disclosure · Other events
- 8-K Event Material agreement
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- S-8 Other Securities Offered to Employees in Benefit Plans
Page 3 of 45 · 886 filings